184 related articles for article (PubMed ID: 25697559)
1. Effect of linker flexibility and length on the functionality of a cytotoxic engineered antibody fragment.
Klement M; Liu C; Loo BL; Choo AB; Ow DS; Lee DY
J Biotechnol; 2015 Apr; 199():90-7. PubMed ID: 25697559
[TBL] [Abstract][Full Text] [Related]
2. Monospecific bivalent scFv-SH: effects of linker length and location of an engineered cysteine on production, antigen binding activity and free SH accessibility.
Albrecht H; Denardo GL; Denardo SJ
J Immunol Methods; 2006 Mar; 310(1-2):100-16. PubMed ID: 16499921
[TBL] [Abstract][Full Text] [Related]
3. Properties of a single-chain antibody containing different linker peptides.
Alfthan K; Takkinen K; Sizmann D; Söderlund H; Teeri TT
Protein Eng; 1995 Jul; 8(7):725-31. PubMed ID: 8577701
[TBL] [Abstract][Full Text] [Related]
4. Effect of Linker Length and Flexibility on the Clostridium thermocellum Esterase Displayed on Bacillus subtilis Spores.
Chen H; Wu B; Zhang T; Jia J; Lu J; Chen Z; Ni Z; Tan T
Appl Biochem Biotechnol; 2017 May; 182(1):168-180. PubMed ID: 27933482
[TBL] [Abstract][Full Text] [Related]
5. Construction of a linker library with widely controllable flexibility for fusion protein design.
Li G; Huang Z; Zhang C; Dong BJ; Guo RH; Yue HW; Yan LT; Xing XH
Appl Microbiol Biotechnol; 2016 Jan; 100(1):215-25. PubMed ID: 26394862
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
Colcher D; Pavlinkova G; Beresford G; Booth BJ; Choudhury A; Batra SK
Q J Nucl Med; 1998 Dec; 42(4):225-41. PubMed ID: 9973838
[TBL] [Abstract][Full Text] [Related]
7. Design and characterization of structured protein linkers with differing flexibilities.
Klein JS; Jiang S; Galimidi RP; Keeffe JR; Bjorkman PJ
Protein Eng Des Sel; 2014 Oct; 27(10):325-30. PubMed ID: 25301959
[TBL] [Abstract][Full Text] [Related]
8. Intrabody construction and expression. II. A synthetic catalytic Fv fragment.
Ohage EC; Wirtz P; Barnikow J; Steipe B
J Mol Biol; 1999 Sep; 291(5):1129-34. PubMed ID: 10518948
[TBL] [Abstract][Full Text] [Related]
9. Multimerization of a chimeric anti-CD20 single-chain Fv-Fc fusion protein is mediated through variable domain exchange.
Wu AM; Tan GJ; Sherman MA; Clarke P; Olafsen T; Forman SJ; Raubitschek AA
Protein Eng; 2001 Dec; 14(12):1025-33. PubMed ID: 11809933
[TBL] [Abstract][Full Text] [Related]
10. A tetravalent single-chain antibody-streptavidin fusion protein for pretargeted lymphoma therapy.
Schultz J; Lin Y; Sanderson J; Zuo Y; Stone D; Mallett R; Wilbert S; Axworthy D
Cancer Res; 2000 Dec; 60(23):6663-9. PubMed ID: 11118050
[TBL] [Abstract][Full Text] [Related]
11. Antibody engineering of a cytotoxic monoclonal antibody 84 against human embryonic stem cells: Investigating the effects of multivalency on cytotoxicity.
Klement M; Zheng J; Liu C; Tan HL; Wong VV; Choo AB; Lee DY; Ow DS
J Biotechnol; 2017 Feb; 243():29-37. PubMed ID: 28042013
[TBL] [Abstract][Full Text] [Related]
12. Improved affinity coupling for antibody microarrays: engineering of double-(His)6-tagged single framework recombinant antibody fragments.
Steinhauer C; Wingren C; Khan F; He M; Taussig MJ; Borrebaeck CA
Proteomics; 2006 Aug; 6(15):4227-34. PubMed ID: 16826567
[TBL] [Abstract][Full Text] [Related]
13. Fast antibody fragment motion: flexible linkers act as entropic spring.
Stingaciu LR; Ivanova O; Ohl M; Biehl R; Richter D
Sci Rep; 2016 Mar; 6():22148. PubMed ID: 27020739
[TBL] [Abstract][Full Text] [Related]
14. Targeting and therapy of carcinoembryonic antigen-expressing tumors in transgenic mice with an antibody-interleukin 2 fusion protein.
Xu X; Clarke P; Szalai G; Shively JE; Williams LE; Shyr Y; Shi E; Primus FJ
Cancer Res; 2000 Aug; 60(16):4475-84. PubMed ID: 10969795
[TBL] [Abstract][Full Text] [Related]
15. Generation of antibody molecules through antibody engineering.
Kipriyanov SM
Methods Mol Biol; 2003; 207():3-25. PubMed ID: 12412465
[No Abstract] [Full Text] [Related]
16. Construction and characterization of novel, recombinant immunotoxins targeting the Her2/neu oncogene product: in vitro and in vivo studies.
Cao Y; Marks JD; Marks JW; Cheung LH; Kim S; Rosenblum MG
Cancer Res; 2009 Dec; 69(23):8987-95. PubMed ID: 19934334
[TBL] [Abstract][Full Text] [Related]
17. Fine tuning of spatial arrangement of enzymes in a PCNA-mediated multienzyme complex using a rigid poly-L-proline linker.
Haga T; Hirakawa H; Nagamune T
PLoS One; 2013; 8(9):e75114. PubMed ID: 24040392
[TBL] [Abstract][Full Text] [Related]
18. A study on the effects of linker flexibility on acid phosphatase PhoC-GFP fusion protein using a novel linker library.
Huang Z; Li G; Zhang C; Xing XH
Enzyme Microb Technol; 2016 Feb; 83():1-6. PubMed ID: 26777244
[TBL] [Abstract][Full Text] [Related]
19. Designing cell-targeted therapeutic proteins reveals the interplay between domain connectivity and cell binding.
Robinson-Mosher A; Chen JH; Way J; Silver PA
Biophys J; 2014 Nov; 107(10):2456-66. PubMed ID: 25418314
[TBL] [Abstract][Full Text] [Related]
20. [Expression, structure prediction and functional analysis of murine single-chain fragment variable antibody against human cervical cancer].
Wang Y; Li X; Chen W
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan; 26(1):16-21. PubMed ID: 16495168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
